Silver Book Fact

Studies of patients with myocardial infarction found that warfarin reduced stroke risk compared to placebo
by 40% to 55%.

ASPECT (Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis) Group. Effect of Long- Term Oral Anticoagulant Treatment on Mortality and Cardiovascular Morbidity After Myocardial Infarction. Lancet. 1994; 343(8896): 499-503. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2894%2991458-3/abstract

Reference

Title
Effect of Long- Term Oral Anticoagulant Treatment on Mortality and Cardiovascular Morbidity After Myocardial Infarction
Publication
Lancet
Publication Date
1994
Authors
ASPECT (Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis) Group
Volume & Issue
Volume 343, Issue 8896
Pages
499-503
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Timely treatment and follow-up care can reduce the risk of blindness in individuals with proliferative retinopathy by 95%.  
  • Screening and treatment for diabetic retinopathy in type 2 diabetes patients produces annual savings of 53,986 person-years of sight.  
  • Lucentis to treat wet age-related macular degeneration (AMD)
    An FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)–ranibizumab (Lucentis)–maintained vision in 95% of clinical trial participants and improved vision by 15 or more letters in approximately 25%…  
  • A study on the impact of diet on age-related macular degeneration (AMD) found that those who took the highest amounts of carotenoids, such as lutein and zeaxanthin, had a 43%…  
  • After 54 weeks of receiving bevacizumab, wet age-realted macular degeneration (AMD) patients were more likely to gain at least 6 letters of contrast sensitivity than patikents recieving standard care–35.4% versus…